Bausch Health Companies BHC Deferred Tax Assets, Valuation Allowance
Deferred Tax Assets, Valuation Allowance at other companies
Other financials
Where this comes from
Reported directly by Bausch Health Companies in its filing.
Tagged under the XBRL concept us-gaap:DeferredTaxAssetsValuationAllowance.
The official record: Bausch Health Companies’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bausch Health Companies's deferred tax assets, valuation allowance.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bausch Health Companies's deferred tax assets, valuation allowance?
- Bausch Health Companies (BHC) reported deferred tax assets, valuation allowance of $2.7B in Q1 2026.
- How has Bausch Health Companies's deferred tax assets, valuation allowance changed year-over-year?
- Bausch Health Companies's deferred tax assets, valuation allowance increased by 15.0% year-over-year, from $2.34B to $2.7B.
- What is the long-term trend for Bausch Health Companies's deferred tax assets, valuation allowance?
- Over 3 years (2022 to 2025), Bausch Health Companies's deferred tax assets, valuation allowance has grown at a 5.4% compound annual growth rate (CAGR), from $2.2B to $2.58B.